BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales


12/5/2007 12:55:09 PM

SUNNYVALE, Calif., Dec. 5 /PRNewswire-FirstCall/ -- FlowCardia, Inc., a medical device company developing endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, today announced the appointment of Christopher R. Barys to the position of Senior Vice President, Sales. Mr. Barys comes to FlowCardia with over 16 years of experience in Medical Devices, 12 years of which have been in the interventional endovascular products field.

Most recently, Mr. Barys served as Vice President of Sales and Marketing for the Peripheral Vascular Systems business for Edwards Lifesciences where he had broad responsibility for this rapidly growing business segment. Previously, Mr. Barys held Senior Sales and Marketing positions at Johnson & Johnson's Cordis Division, Boston Scientific and U.S. Surgical.

"We are tremendously pleased that Chris will be joining FlowCardia at this important time for the Company. His extensive experience in leading large national sales forces will be very valuable as FlowCardia initiates the immediate launch of its CROSSER System to Interventional Cardiologists, Interventional Radiologists and Vascular Surgeons," said Wick Goodspeed, President and CEO of FlowCardia. "I am confident that Chris will be a substantial contributor to our commercialization success in 2008 and the coming years."

"This is an exciting time to be joining FlowCardia. I look forward to working closely with Wick and the rest of the management team at the Company," said Mr. Barys. "FlowCardia is on the cusp of rapid growth and I am enthusiastic about the opportunity to introduce a significantly less invasive therapeutic option for coronary and peripheral CTO patients."

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture safe and effective, endovascular CTO recanalization systems. Additional information is available on the Company's Web Site at http://www.flowcardia.com.

CONTACT: Mark Page, Sr. Director, Marketing of FlowCardia, Inc.,
+1-408-617-0352, ext. 301

Web site: http://www.flowcardia.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES